ダウンロード数: 403
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
65_2_33.pdf | 1.33 MB | Adobe PDF | 見る/開く |
タイトル: | 視力障害を契機に診断された腎癌脈絡膜転移の1例 |
その他のタイトル: | A Case of Renal Cell Carcinoma Choroidal Metastasis Diagnosed from Vision Disorders |
著者: | 今井, 悠 松浦, 泰史 久金, 陽 森武, 潤 坂東, 重浩 山田, 裕紀 清田, 浩 飯田, 貴絵 頴川, 晋 |
著者名の別形: | Imai, Yu Matsuura, Taishi Hisakane, Akira Moritake, Jun Bando, Shigehiro Yamada, Hiroki Kiyota, Hiroshi Iida, Kie Egawa, Shin |
キーワード: | Renal cell carcinoma Choroidal metastasis Metastatic eye tumor |
発行日: | 28-Feb-2019 |
出版者: | 泌尿器科紀要刊行会 |
誌名: | 泌尿器科紀要 |
巻: | 65 |
号: | 2 |
開始ページ: | 33 |
終了ページ: | 37 |
抄録: | A 69-year-old male with the complaint of a cough was referred to our hospital from a clinic where he was found to have simultaneous metastases of the left kidney tumor. We performed left cytoreductive nephrectomy, and administered sunitinib after the surgery. The first line treatment was not effective. Then we changed the therapeutic agent to pazopanib as the second line treatment. Lung and lymph node metastases gradually shrunk, but he developed right vision disorders and was diagnosed with bilateral metastatic retinal tumors. First, irradiation to the right eye was performed while discontinuing pazopanib. Sudden treatment withdrawal caused his general condition to worsen temporally, but irradiation could be continued by resuming administration of pazopanib. As a consequence, the progression of the visual field disorder was suppressed by the additional ophthalmologic treatment. Renal cell carcinoma choroidal metastases are rare, but we need to consider them when the patient has vision disorders. |
著作権等: | 許諾条件により本文は2020/03/01に公開 |
DOI: | 10.14989/ActaUrolJap_65_2_33 |
URI: | http://hdl.handle.net/2433/241220 |
PubMed ID: | 31067840 |
出現コレクション: | Vol.65 No.2 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。